Factors predictive of death among HIV‐uninfected persons with haemophilia and other congenital coagulation disorders

Laura S. Diamondstone(United States Department of Health and Human Services), J. J. Goedert(Penn State Milton S. Hershey Medical Center), Louis M. Aledort(Icahn School of Medicine at Mount Sinai)
Haemophilia
August 28, 2002
10.1046/j.1365-2516.2002.00651.x
Cited by 20

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587